Clinic
Bridgeport Family Medicine LLC
Bridgeport Family Medicine LLC was paid $7.35M by Medicaid between Jan 2018 and Dec 2024, across 46 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 49% of everything it billed.
33Billing provider infoBRIDGEPORT FAMILY MEDICINE LLC
BRIDGEPORT, CT 06604
BRIDGEPORT, CT 06604
33aNPI1548642283assigned 06/18/2015
33bProvider typeUrgent Care Clinic/Center
28Total paid$7.35M
24GClaims136,682
24DCodes billed46
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Connecticut
Rank by total paid#4 of 21
Median peer was paid$606K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,292 | $894K | |
| 2019 | 15,257 | $809K | |
| 2020 | 18,537 | $1.13M | |
| 2021 | 28,991 | $1.28M | |
| 2022 | 22,797 | $1.19M | |
| 2023 | 19,449 | $1.11M | |
| 2024incomplete | 15,359 | $943K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 49% | 57,728 | 45,463 | $3.63M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 21,375 | 18,535 | $1.81M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 10% | 7,783 | 7,196 | $770K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.7% | 2,911 | 2,626 | $422K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.2% | 4,150 | 3,434 | $163K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 3,193 | 2,904 | $98K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.0% | 659 | 630 | $76K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 528 | 491 | $62K |
| 99051 | <1% | 8,541 | 7,680 | $54K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 863 | 734 | $54K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,630 | 2,330 | $31K |
| 93000 | <1% | 2,336 | 2,159 | $28K |
34 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,609 | $24K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,164 | $21K |
| 99050 | <1% | 1,584 | $19K | |
| 90674 | <1% | 976 | $17K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 118 | $13K |
| 99173 | <1% | 1,970 | $11K | |
| 90686 | <1% | 1,069 | $8K | |
| 99385 | <1% | 46 | $6K | |
| 96127 | <1% | 412 | $6K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 43 | $6K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 38 | $4K |
| 99201 | <1% | 110 | $4K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 175 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 281 | $3K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,419 | $2K |
| 99454 | <1% | 184 | $2K | |
| 81000 | <1% | 556 | $1K | |
| 99457 | <1% | 126 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 348 | $1K |
| 90715 | <1% | 37 | $671.91 | |
| 86580 | <1% | 104 | $600.96 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $457.16 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 271 | $445.49 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 48 | $316.72 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 17 | $252.00 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 8,806 | $211.14 |
| 81025 | <1% | 24 | $144.96 | |
| 99453 | <1% | 18 | $97.27 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 14 | $41.78 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 74 | $35.46 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 39 | $0.84 |
| 81002 | 0% | 102 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 78 | $0.00 |
| 99000 | 0% | 113 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMALIK, AWAIS (MEDICAL DIRECTOR)